SCHEMBL7096970

SCHEMBL7096970

CCOC(=O)c1ccc(/N=c2/sc3ncccc3c(=O)n2C)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.52
SMN1; SMN2 Q16637 5/20 0.52
NPC1 O15118 4/20 0.52
RAB9A P51151 3/20 0.52
HPGD P15428 2/20 0.52
CYP1A2 P05177 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
HTT P42858 2/20 0.47
ALDH1A1 P00352 6/20 0.47
LMNA P02545 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
GAA P10253 2/20 0.45
KDM4E B2RXH2 2/20 0.45
CACNA1B Q00975 1/20 0.45
APBA1 Q02410 1/20 0.45
APOBEC3G Q9HC16 1/20 0.45
USP2 O75604 1/20 0.45
NPSR1 Q6W5P4 2/20 0.43
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7096971 1.00 MAPT (0.52) MAPTSMN1; SMN2NPC1RAB9AHPGD
SCHEMBL7096508 0.89 SMN1; SMN2 (0.49) MAPTSMN1; SMN2NPC1RAB9AHPGD
SCHEMBL7096507 0.89 SMN1; SMN2 (0.49) MAPTSMN1; SMN2NPC1RAB9AHPGD
SCHEMBL7096458 0.84 MEN1 (0.50) MAPTSMN1; SMN2NPC1RAB9AHPGD
SCHEMBL7096459 0.84 MEN1 (0.50) MAPTSMN1; SMN2NPC1RAB9AHPGD
SCHEMBL7099114 0.83 KAT2B (0.50) MAPTSMN1; SMN2NPC1RAB9AHPGD
SCHEMBL7099117 0.83 KAT2B (0.50) MAPTSMN1; SMN2NPC1RAB9AHPGD
SCHEMBL7099733 0.81 KAT2B (0.46) MAPTNPC1RAB9AHTTALDH1A1
SCHEMBL7099729 0.81 KAT2B (0.46) MAPTNPC1RAB9AHTTALDH1A1
SCHEMBL7096300 0.80 KAT2B (0.54) MAPTSMN1; SMN2NPC1RAB9ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0878196-B1 KAINIC ACID NEURONOTOXICITY INHIBITORS AND PYRIDOTHIAZINE DERIVATIVES YAMANOUCHI PHARMA CO LTD (JP) 2003-09-03 EP disclosed
US-6133258-A PYRIDOTHIAZINE DERIVATIVE; FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS, MULTIPLE SCLEROSIS, PAIN, GLAUCOMA YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 2000-10-17 US disclosed
EP-0878196-A1 KAINIC ACID NEURONOTOXICITY INHIBITORS AND PYRIDOTHIAZINE DERIVATIVES YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1998-11-18 EP disclosed